Wednesday, Dec 01, 2021 | Last Update : 11:45 PM IST

FabiFlu

FabiFlu more economical, effective treatment option for COVID-19: Glenmark tells DGCI

Glenmark also denied making any claims that “favipiravir alone” is effective in treatment of mild-to-moderate COVID-19 patients

21 Jul 2020 3:38 PM

Glenmark Pharma cuts price of COVID-19 drug Favipiravir to Rs 75/tablet

Glenmark Pharmaceuticals had launched antiviral drug Favipiravir, under the brand name FabiFlu, last month at a price of Rs 103 per tablet

13 Jul 2020 2:53 PM

ADVERTISEMENT
ADVERTISEMENT